SEC Form 4 · accession 0000899243-16-022404
NovoCure Ltd · NVCR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael J. Ambrogi
Officer — Chief Operating Officer
Period of report
Jun 8, 2016
Accepted (ET)
Jun 10, 2016 · 4:08 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001645113
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | Jun 8, 2016 | S | 10,000 | $12.21 | D | 324,084 | D | |
| Ordinary Shares | Jun 8, 2016 | S | 10,000 | $12.27 | D | 314,084 | D |
Table II — derivative securities
No Table II lines on this filing.